Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
23,339,932
-
Share change
-
-112,852
-
Total reported value
-
$148,655,458
-
Price per share
-
$6.38
-
Number of holders
-
68
-
Value change
-
-$1,934,833
-
Number of buys
-
33
-
Number of sells
-
22
Institutional Holders of KALA BIO INC COM NEW - Stock (KALA) as of Q2 2019
As of 30 Jun 2019,
KALA BIO INC COM NEW - Stock (KALA) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,339,932 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, ORBIMED ADVISORS LLC, Polaris Venture Management Co. V, L.L.C., BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, CAXTON CORP, Athyrium Capital Management, LP, VANGUARD GROUP INC, Vivo Capital, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.